image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates & Ideas

Open Orphan’s - Virology services growing like topsy

January 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ORPH
  • Price:
  • 22p
Open Orphan’s (ORPH; 22p) chairman, Cathal Friel, notes that most vaccines were developed 25-30 years ago and the pandemic has heightened the need for better performing antivirals, with pharma companies increasing their funding into vaccines and future pandemic prevention. The world is getting more crowded, more connected, and the worlds of humans and animals are increasingly converging. All four pandemics in the last 100 years have had viruses skipping over from birds and as for Covid, they say it came from bats and pangolins but who knows? ORPH was formed following a three way merger of Open Orphan, Venn and hVIVO in 2019. None of the businesses had made much headway on their own but since coming together, Friel has made signific ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW